Cloverfields Capital Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$3.93M |
| 2 |
SPDR Gold Trust
GLD
|
+$2.45M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$2.11M |
| 4 |
Valaris
VAL
|
+$1.99M |
| 5 |
Estee Lauder
EL
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$68.7M |
| 2 |
MASI
Masimo
MASI
|
+$3.48M |
| 3 |
Dollar General
DG
|
+$3.13M |
| 4 |
Brookfield
BN
|
+$2.44M |
| 5 |
Novartis
NVS
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.39% |
| 2 | Technology | 11.6% |
| 3 | Financials | 10.72% |
| 4 | Industrials | 8.51% |
| 5 | Energy | 7.85% |
Similar funds
Cloverfields Capital Group's Q2 2023 Portfolio in Review
As of Q2 2023, Cloverfields Capital Group held 84 positions worth $310M, down 7.5% from $335M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Cloverfields Capital Group withdrew a net $41.6M in Q2 2023, closing 7 positions and reducing 2 holdings. Its most notable exit was Masimo, an estimated $3.48M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 55% a quarter earlier, followed by Technology and Financials.
Against the trend, Cloverfields Capital Group opened a new position in Berkshire Hathaway Class B worth $4.11M.
- Cloverfields Capital Group's largest Q2 2023 buy was Berkshire Hathaway Class B: 12,043 shares worth $4.11M.
- Cloverfields Capital Group added most to Canadian Pacific Kansas City in Q2 2023, an estimated $2.11M increase.
- Cloverfields Capital Group's biggest Q2 2023 reduction was UnitedHealth, cutting an estimated $68.7M.
- Cloverfields Capital Group fully exited Masimo in Q2 2023, selling an estimated $3.48M.
- Cloverfields Capital Group's ten largest holdings make up 52% of its $310M portfolio in Q2 2023.
- Cloverfields Capital Group opened 5 new positions and closed 7 in Q2 2023.
- Cloverfields Capital Group's portfolio value fell 7.5% quarter-over-quarter to $310M.
Based on Cloverfields Capital Group's 13F filing for Q2 2023, filed 14 Aug 2023.